Integrin Signaling and ECM Proteins in hPSC Maintenance and Differentiation
Frontiers in Bioscience-Landmark · 21.01.2026 · 31 (1)
DOI: 10.31083/fbl46332 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 21.01.2026. Verfasst von Tianchen Wei und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: Cell Differentiation, Integrins, Pluripotent Stem Cells, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Maryland Stem Cell Research Fund.
Abstract (Originalsprache)
Integrin signaling serves as a fundamental regulator in human pluripotent stem cell (hPSC) biology, mediating adhesion, survival, and pluripotency through interactions with extracellular matrix (ECM) components. Specific integrins, including α6β1, αvβ5, and α3β1, engage ECM ligands such as laminin-511/521 and vitronectin (VTN) to sustain hPSC self-renewal. These engagements trigger essential downstream pathways, including PI3K/AKT, MAPK/ERK, focal adhesion kinase (FAK)-Src, and RhoA/Rho-associated protein kinase (ROCK), thereby maintaining the expression of pluripotency factors like OCT4, NANOG, and SOX2 while integrating mechanotransductive cues. FAK and Src convert ECM-derived mechanical signals into biochemical responses, regulating cytoskeletal reorganization, YAP/TAZ nuclear translocation, and context-dependent gene expression. For scalable, xeno-free culture, recombinant substrates such as truncated vitronectin (VTN-N) and laminin-511/521 E8 fragments, paired with defined media (e.g., Essential 8 or mTeSR1), support robust hPSC expansion under good manufacturing practice (GMP) conditions. Extending to differentiation, integrin-ECM crosstalk directs lineage commitment across diverse fates, including hematopoietic, cardiovascular, neural, hepatic, epithelial, endodermal, and oligodendroglial lineages, by fine-tuning signaling specificity and ECM composition. This review focuses on recent advances in the mechanistic interplay between integrin signaling and ECM proteins in hPSC maintenance, mechanotransduction, and lineage-directed differentiation, emphasizing defined culture systems and their translational potential in regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Biotechnology in Advanced Academic Programs, Krieger School of Arts & Sciences, Johns Hopkins University, Baltimore, MD 21218, USA.
Förderung
- Maryland Stem Cell Research Fund
Zitieren
APA
Wei, T., & Wang, Z. Z. (2026). Integrin Signaling and ECM Proteins in hPSC Maintenance and Differentiation. Frontiers in Bioscience-Landmark, 31(1). https://doi.org/10.31083/fbl46332
Vancouver
Wei T, Wang ZZ. Integrin Signaling and ECM Proteins in hPSC Maintenance and Differentiation. Frontiers in Bioscience-Landmark. 2026;31(1). doi:10.31083/fbl46332
BibTeX
@article{Wei2026,
author = {Wei, Tianchen and Wang, Zack Z},
title = {Integrin Signaling and ECM Proteins in hPSC Maintenance and Differentiation},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {1},
doi = {10.31083/fbl46332}
}
EUVIMED